P1 (Pramipexole dihydrochloride 0.125 mg)
Pill imprint P1 has been identified as Pramipexole dihydrochloride 0.125 mg.
Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.125 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 0.125 mg
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Zydus Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- D&C Red No. 27
pregelatinized corn starch
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|68084-0793||Amerisource Health Services|
More about pramipexole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 125 Reviews – Add your own review/rating
- Drug class: dopaminergic antiparkinsonism agents
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.